Special Research Seminar - Paolo Tarantino, M.D., Ph.D.

Sponsored by Simmons Comprehensive Cancer Center

" Reinventing HER2: From Binary to Spectrum to Precision ADC Therapy"

Paolo Tarantino, M.D., Ph.D.

Breast Cancer Oncologist

Advanced Fellow, Dana-Farber Cancer Institute | Harvard Medical School

Tuesday, September 8th | 4:00pm

NB5.124 Seminar Room ( In Person Preferred)

ZOOM | Meeting ID: 926 6176 5502 | Passcode: 489650

About Dr. Paolo Tarantino:

Paolo Tarantino is a breast medical oncologist and advanced fellow at Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA. He received his medical degree from the University Federico II of Naples, Italy, and completed his medical oncology training at the University of Milan, where he also earned a PhD in Clinical Research.

Dr. Tarantino’s research focuses on antibody-drug conjugates (ADCs), with particular interest in biomarker development and strategies to optimize ADC use across solid tumors. He has authored more than 130 scientific publications and is actively involved in multiple clinical and translational studies investigating ADC-based treatment approaches.